Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition.
血清 PCSK9（前蛋白转化酶枯草杆菌蛋白酶/Kexin 9 型）的变化、心血管疾病风险以及对 PCSK9 抑制的潜在意外影响的研究
期刊:Circulation-Genomic and Precision Medicine
影响因子:5.5
doi:10.1161/CIRCGEN.118.002335
Brumpton Ben M, Fritsche Lars G, Zheng Jie, Nielsen Jonas Bille, Mannila Maria, Surakka Ida, Rasheed Humaira, Vie Gunnhild à berge, Graham Sarah E, Gabrielsen Maiken Elvestad, Laugsand Lars Erik, Aukrust Pål, Vatten Lars Johan, Damås Jan Kristian, Ueland Thor, Janszky Imre, Zwart John-Anker, Van't Hooft Ferdinand M, Seidah Nabil Georges, Hveem Kristian, Willer Cristen, Smith George Davey, à svold Bjørn Olav
